Filing Details

Accession Number:
0000904454-15-000232
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-03 16:49:42
Reporting Period:
2015-04-01
Filing Date:
2015-04-03
Accepted Time:
2015-04-03 16:49:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1457612 Genocea Biosciences Inc. GNCA Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591868 Baker Jessica Flechtner C/O Genocea Biosciences, Inc.
100 Acorn Drive, 5Th Floor
Cambridge MA 02140
Sr. Vp Of Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-01 2,283 $2.86 4,164 No 4 M Direct
Common Stock Disposition 2015-04-01 2,283 $11.77 1,881 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-04-01 2,283 $0.00 2,283 $2.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-03-27 No 4 M Direct
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The option was granted on 3/28/2010 and will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.